Bookmark and Share
glycogen synthase kinase-3 alpha [Homo sapien.. [gi:49574532] - Target BioActivity Data
Also known as: glycogen synthase kinase-3 alpha [Homo sapiens].
Filters: All Data » Active      
Filter selected
BioActivity Outcomes:
Active(1145)
 
 
BioAssay Types:
Confirmatory(827)
 
 
Screening(318)
 
 
BioActivity Types:
AC50(827)
 
 
Substance Types:
Chemical(1145)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 5    Data Row: 1145   Total Pages: 23   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID49674818]
[CID11405589]
AC50_uM 0.0135Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
2
[SID49674819]
[CID176158]
AC50_uM 0.02Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
3
[SID103023249]
[CID661958]
AC50_uM 0.0218Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
4
[SID103023240]
[CID9558362]
AC50_uM 0.0219Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623978, Type: confirmatory]
View
5
[SID103023235]
[CID46500289]
AC50_uM 0.0392Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
6
[SID74374076]
[CID53313071]
AC50_uM 0.105Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
7
[SID104170299]
[CID6539118]
AC50_uM 0.121Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623978, Type: confirmatory]
View
8
[SID104170299]
[CID6539118]
AC50_uM 0.144Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
9
[SID103023211]
[CID936046]
AC50_uM 0.168Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623978, Type: confirmatory]
View
10
[SID87219187]
[CID6539118]
AC50_uM 0.206Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
11
[SID859474]
[CID660775]
AC50_uM 0.2109Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
12
[SID859094]
[CID660396]
AC50_uM 0.2344Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
13
[SID49820366]
[CID5927014]
AC50_uM 0.2431Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
14
[SID103023202]
[CID3294594]
AC50_uM 0.276Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
15
[SID87219187]
[CID6539118]
AC50_uM 0.281Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623978, Type: confirmatory]
View
16
[SID103023243]
[CID660516]
AC50_uM 0.288Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
17
[SID49641385]
[CID3163532]
AC50_uM 0.3121Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
18
[SID103023246]
[CID10114110]
AC50_uM 0.361Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623978, Type: confirmatory]
View
19
[SID103023248]
[CID5727763]
AC50_uM 0.367Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
20
[SID124360055]
[CID3541811]
AC50_uM 0.388Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity [AID588361, Type: confirmatory]
View
21
[SID49815772]
[CID5729339]
AC50_uM 0.3966Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
22
[SID103023228]
[CID6891123]
AC50_uM 0.422Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
23
[SID103023245]
[CID3773561]
AC50_uM 0.429Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
24
[SID103023222]
[CID4432160]
AC50_uM 0.459Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
25
[SID17401642]
[CID6037979]
AC50_uM 0.4626Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
26
[SID103023239]
[CID9666997]
AC50_uM 0.474Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623978, Type: confirmatory]
View
27
[SID103023218]
[CID49766509]
AC50_uM 0.52Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
28
[SID103023231]
[CID6879081]
AC50_uM 0.597Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
29
[SID49828660]
[CID9670849]
AC50_uM 0.6138Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
30
[SID14733407]
[CID4414227]
AC50_uM 0.6486Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
31
[SID862346]
[CID663574]
AC50_uM 0.6753Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
32
[SID124360059]
[CID3732306]
AC50_uM 0.698Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity [AID588361, Type: confirmatory]
View
33
[SID49829122]
[CID9629858]
AC50_uM 0.7792Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
34
[SID124360052]
[CID5337380]
AC50_uM 0.828Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity [AID588361, Type: confirmatory]
View
35
[SID26725679]
[CID5932055]
AC50_uM 0.8446Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
36
[SID49825093]
[CID6891427]
AC50_uM 0.8988Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
37
[SID124360051]
[CID3301535]
AC50_uM 0.953Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity [AID588361, Type: confirmatory]
View
38
[SID17514893]
[CID12005913]
AC50_uM 0.9801Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
39
[SID103023219]
[CID6905154]
AC50_uM 0.984Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
40
[SID124360062]
[CID53245482]
AC50_uM 0.989Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity [AID588361, Type: confirmatory]
View
41
[SID17505226]
[CID5441926]
AC50_uM 1.016Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
42
[SID49819869]
[CID9639903]
AC50_uM 1.017Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
43
[SID49815773]
[CID24816495]
AC50_uM 1.023Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
44
[SID49819813]
[CID9642348]
AC50_uM 1.026Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
45
[SID49828658]
[CID9656830]
AC50_uM 1.039Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
46
[SID49820962]
[CID9689326]
AC50_uM 1.044Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
47
[SID49820963]
[CID6891225]
AC50_uM 1.051Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
48
[SID24828555]
[CID6012776]
AC50_uM 1.064Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
49
[SID49820964]
[CID6290108]
AC50_uM 1.174Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
50
[SID4249000]
[CID3243007]
AC50_uM 1.218Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View